The Hemfosa share

The company’s ordinary share was listed on Nasdaq Stockholm, Mid Cap, on March 21, 2014 under the ticker symbol “HEMF.” The company’s preference share was listed on Nasdaq Stockholm, Mid- Cap, on December 12, 2014 under the ticker symbol “HEMF PREF.” On January 2, 2017, trading in the company’s ordinary shares and preference shares was moved to Nasdaq Stockholm Large Cap.

On June 19, 2018, Hemfosa carried out a directed share issue comprising 10,000,000 ordinary shares. On account of the directed share issue, the company increased its share capital by SEK 5,000,000, which thereafter amounts to SEK 89,364,124. The company received a capital infusion totaling MSEK 1,085 before issue expenses.

At September 30, 2018, the number of Hemfosa shares was 178,728,248, of which 167,728,249 were ordinary shares and 10,999,999 preference shares. The number of voting rights totaled 168,828,248.9. Each ordinary share carries one voting right and each preference share one tenth of a voting right. The last price paid on September 28, 2018 was SEK 122.50 for the ordinary share and SEK 189.50 for the preference share. Total market capitalization was MSEK 22,631. At September 30, 2018, Hemfosa had 26,588 shareholders, of whom Swedish investors, institutions and private individuals owned 52.3 percent of the shares and 50.5 percent of the votes. International institutional investors owned 47.7 percent of the shares and 49.5 percent of the votes.